Incruse Ellipta (umeclidinium)

**Product type:** Human Prescription Drug

**Active ingredient:** UMECLIDINIUM BROMIDE

**Strength:** 62.5 ug/1

**Dosage form:** Aerosol, Powder

**Route:** Oral

**Labeler:** GlaxoSmithKline LLC

**Marketing category:** NDA (NDA205382)

**Pharmacologic class:** Anticholinergic [EPC], Cholinergic Antagonists [MoA]